News & Events

December 2016
MHRA approval granted for the UK based asthma monitoring device clinical study.

September 2016
Appointment of Tim Coutts as CEO.

August 2016
Clinical Trial Devices manufactured and ready for the asthma monitoring device clinical studies.

January 2016
Awarded an Innovate UK Development of Prototype grant with the project title: Anaxsys Technology Ltd Asthma Monitoring Device Pilot Study. This grant is to fund two clinical studies for the development of an asthma monitoring device.

December 2015
Awarded a Horizon 2020 SME Instrument Phase 1 grant for an Asthma Monitoring Device

March 2015
Awarded an Innovate UK Proof of Market Grant for a lung cancer screening device

January 2015
Awarded an Innovate UK Proof of Market Grant for an Asthma Monitoring Device

September 2012

Anaxsys among Top UK health technology companies awarded a place on the Future Health Mission to Boston, 26 September - 3rd Oct, 2012.

See Anaxsys' company video: http://vimeo.com/49718390

May 2011

An article about Anaxsys, ‘Monitoring every breath,’ was published in the ‘Ingenious Britain’ supplement in the Sunday Times.  Please click here to download it.

March 2011
Anaxsys launches respiR8 in Spain. 

January 2011
A clinical study about respiR8, 'Respiratory rate measurement: a comparison of methods,' is published in the British Journal of Healthcare Assistants.

November 2010
respiR8 is launched in the UK.

Anaxsys was present at the 'Difficult Airway Society', Cheltenham. 

September 2010
Anaxsys' respiratory rate counter, respiR8 has been awarded a CE mark. 

May 2010
Anaxsys has concluded the phase 1 project for which it was awarded the SBRI grant and has  received ISO13485-2003 approved for its quality system for the design and manufacture of the respiratory rate monitors and respiratory sensors

April 2010
Anaxsys is pleased to announce that it has completed the clinical  study respiR8 in post operation patients.  This study compared the respiR8 with manual counting.  The device was found to be well tolerated by the patient and well received by healthcare professionals.  The mean difference between the respiR8 and manual counts was less than 1 breath per minute

January 2010
Anaxsys is pleased to announce that it has completed  phase 2 of the funding round opened in 2009, raising a total from this estimated round of £1.73 m